Impact of the COVID-19 pandemic on hepatitis C diagnosis in Brazil: Is the global hepatitis C elimination strategy at risk?

do Carmo, Rodrigo Feliciano; de Souza, Carlos Dornels Freire

do Carmo, Rodrigo Feliciano; de Souza, Carlos Dornels Freire.

do Carmo RF; College of Pharmaceutical Sciences, Federal University of the São Francisco Valley (UNIVASF), Petrolina, Pernambuco, Brazil. Electronic address: rodrigo.carmo@univasf.edu.br.
de Souza CDF; Department of Medicine, Federal University of Alagoas (UFAL), Arapiraca, Brazil.

J Hepatol ; 76(2): 470-472, 2022 02.

Article in English | MEDLINE | ID: covidwho-1370590

Subject(s)

COVID-19; Hepatitis C; Brazil/epidemiology; Hepacivirus; Hepatitis C/diagnosis; Hepatitis C/epidemiology; Hepatitis C/prevention & control; Humans; Pandemics/prevention & control; SARS-CoV-2

Keywords

COVID-19; HCV; coronavirus; elimination; viral hepatitis

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Hepatitis C / COVID-19 Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study Limits: Humans Country/Region as subject: South America / Brazil Language: English Journal: J Hepatol Journal subject: Gastroenterology Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google